NANOMATRONIX LLC — Department of Defense STTR Phase I: AF19C-T010
NANOMATRONIX LLC — STTR Phase I award from Department of Defense.
Phase I STTR feasibility signal
- Phase I awards fund proof-of-concept work. For capture teams, they mark early interest from Department of Defense in a technical approach.
- Watch for Phase II follow-ons from the same firm/topic family — that conversion path is where budgets and transition pressure rise.
- Obligated amount $24,999. Cross-check similar awards in the same agency and technology tags for going-rate context.
- Topic code AF19C-T010 links this award to a solicitation family — search the same topic stem for incumbents and recompete timing.
- Amount
- $24,999
- Agency
- Department of Defense · Air Force
- Program / Phase
- STTR · Phase I
- Topic
- AF19C-T010
- Solicitation
- 19.C
- NAICS
- —
- Place of performance
- AR
- Period
- 2019-12-12 → 2020-12-12
Description
Volumetric muscle loss (VML) is bulk loss of muscle tissue, which overwhelms the body’s capacity for muscle regeneration. The bioSKMR platform is used to create muscle-derived scaffolds, which, when implanted, uses the body’s own wound healing machinery to regenerate muscle. The bioSKMR perfuses freshly harvested muscle tissue with decellularization solution, which rapidly clears muscle of cellular debris and nucleic acids. Using this device, we can decellularize muscle without sacrificing the chemical or architectural properties of the muscle to create muscle scaffolds to treat VML.